The observation that global loss of Gipr protects from diet-induced obesity (177) and that GIP can promote adipocyte lipid storage (163) has inspired the development of GIPR antagonists for the treatment of obesity (182). The gene discussed is GIP; the disease is obesity due to melanocortin 4 receptor deficiency.